Natural History of Non-Small-Cell Lung Cancer with Bone Metastases
2015 · Scientific Reports · 136 citations
https://doi.org/10.1038/srep18670
D
Domenico Galetta
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
383
Papers
7.5K
Citations
43
h-index
123
i10-index
Domenico Galetta is an academic researcher from Istituto Tumori Bari. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Research Studies & Lung Cancer Diagnosis and Treatment. The author has an h-index of 43, co-authored 326 publications.
ORCID: 0000-0002-4878-5906Papers by this author
worksEfficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations
2018 · British Journal of Cancer · 85 citations
https://doi.org/10.1038/s41416-018-0234-3
EGFR mutations and HER2/3 protein expression and clinical outcome in Chinese advanced non-small cell lung cancer patients treated with gefitinib
2008 · Journal of Cancer Research and Clinical Oncology · 44 citations
https://doi.org/10.1007/s00432-008-0512-1
Tobacco control in Europe: A review of campaign strategies for teenagers and adults
2019 · Critical Reviews in Oncology/Hematology · 32 citations
https://doi.org/10.1016/j.critrevonc.2019.01.022
Neutrophil-to-Lymphocyte Ratio Is a Major Prognostic Factor in Non-small Cell Lung Carcinoma Patients Undergoing First Line Immunotherapy With Pembrolizumab
2022 · Cancer Diagnosis & Prognosis · 26 citations
https://doi.org/10.21873/cdp.10178
Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-world data from the Italian expanded access program
2023 · Lung Cancer · 18 citations
https://doi.org/10.1016/j.lungcan.2023.107444
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat